Insulin signalling regulates Pink1 mRNA localization via modulation of AMPK activity to support PINK1 function in

J Tabitha Hees1,2, Simone Wanderoy1,2, Jana Lindner2

  • 1TUM Medical Graduate Center, Technical University of Munich, Munich, Germany.

Nature Metabolism
|March 20, 2024
PubMed

Insights

Insulin signaling prevents Pink1 mRNA from binding to mitochondria, which is crucial for PINK1 activation and mitophagy. This metabolic control is disrupted in Alzheimer

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondrial quality control is vital for neuronal health and often fails in neurodegenerative diseases.
  • PTEN-induced kinase 1 (PINK1) detects damaged mitochondria, a process dependent on Pink1 mRNA localization to mitochondria.
  • AMP-activated protein kinase (AMPK) is a key energy sensor in cells.

Purpose of the Study:

  • To investigate the role of insulin and AMPK signaling in regulating Pink1 mRNA localization and PINK1 activity.
  • To elucidate the molecular mechanism by which insulin signaling affects Pink1 mRNA binding to mitochondria.
  • To explore the link between insulin resistance, apolipoprotein E4, and mitochondrial dysfunction in the context of neurodegeneration.

Main Methods:

  • Investigated the effect of insulin signaling activation on Pink1 mRNA binding to mitochondria.
  • Utilized biochemical assays to identify the phosphorylation site on SYNJ2BP targeted by AMPK.
  • Examined the impact of insulin resistance induced by apolipoprotein E4 on Pink1 mRNA localization and PINK1 activity in neuronal models.

Main Results:

  • Insulin signaling activation inhibits Pink1 mRNA binding to mitochondria by preventing AMPK-mediated phosphorylation of SYNJ2BP.
  • Loss of mitochondrial Pink1 mRNA association is essential for PINK1 protein activation and mitophagy.
  • Insulin resistance, particularly with apolipoprotein E4, causes aberrant Pink1 mRNA retention at mitochondria, impairing PINK1 activity, especially in neuronal processes.

Conclusions:

  • Insulin and AMPK signaling act as a metabolic switch controlling Pink1 mRNA localization and subsequent PINK1 activity in neurons.
  • This pathway provides a mechanistic link between metabolic disturbances like insulin resistance and mitochondrial dysfunction observed in neurodegenerative diseases such as Alzheimer's disease.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K